Skip to content

Clinical trials

Phase 2 Lipid Metabolism Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Phase: Phase 2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20111
20131
20141
20171
20182
20203
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting1
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akcea Therapeutics2
Caliway Biopharmaceuticals Co., Ltd.2
Eli Lilly and Company2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Baylor College of Medicine1
Catabasis Pharmaceuticals1
Furiex Pharmaceuticals, Inc1
Kastle Therapeutics, LLC1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders17
Dyslipidemias11
Metabolic Diseases9
Hyperlipidemias7
Hypercholesterolemia5
Hypertriglyceridemia5
Hyperlipoproteinemias3
Adiposis Dolorosa2
Atherosclerosis2
Cardiovascular Diseases2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.